Rhumbline Advisers Recursion Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 281,348 shares of RXRX stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

281,348

Previous 226,772 24.07%

Holding current value

$1.95 Million

Previous $2.26 Million 6.64%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$7.35 - $10.05 $401,133 - $548,488	54,576 Added 24.07%	281,348 $2.11 Million
Q1 2024 May 09, 2024	BUY	$9.13 - $15.52 $70,346 - $119,581	7,705 Added 3.52%	226,772 $2.26 Million
Q4 2023 Feb 08, 2024	SELL	$5.09 - $10.79 $10,862 - $23,025	-2,134 Reduced 0.96%	219,067 $2.16 Million
Q3 2023 Nov 09, 2023	SELL	$6.59 - $15.86 $242,340 - $583,235	-36,774 Reduced 14.25%	221,201 $1.69 Million
Q2 2023 Aug 08, 2023	BUY	$4.56 - $9.94 $219,322 - $478,084	48,097 Added 22.92%	257,975 $1.93 Million
Q1 2023 May 11, 2023	BUY	$6.42 - $9.64 $27,548 - $41,365	4,291 Added 2.09%	209,878 $1.4 Million
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $6,179 - $10,960	863 Added 0.42%	205,587 $1.59 Million
Q3 2022 Nov 10, 2022	BUY	$7.83 - $13.6 $125,734 - $218,388	16,058 Added 8.51%	204,724 $2.18 Million
Q2 2022 Aug 11, 2022	BUY	$5.04 - $9.26 $326,460 - $599,807	64,774 Added 52.28%	188,666 $1.54 Million
Q1 2022 May 12, 2022	BUY	$6.16 - $18.03 $29,678 - $86,868	4,818 Added 4.05%	123,892 $887,000
Q4 2021 Feb 10, 2022	BUY	$16.14 - $21.86 $1.51 Million - $2.05 Million	93,790 Added 370.95%	119,074 $2.04 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $84,987 - $184,579	4,466 Added 21.45%	25,284 $582,000
Q2 2021 Aug 05, 2021	BUY	$18.0 - $37.42 $374,724 - $779,009	20,818 New	20,818 $760,000

Others Institutions Holding RXRX

# of Institutions

290

Shares Held

239M

Call Options Held

984K

Put Options Held

2.4M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.25B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Recursion Pharmaceuticals, Inc. Transaction History